Literature DB >> 29322788

MicroRNA-421 inhibits caspase-10 expression and promotes breast cancer progression.

T B Hu, H S Chen, M Q Cao, F D Guo, X Y Cheng, Z B Han, M Q Li.   

Abstract

Breast cancer is one of the most prevalent and fatal diseases around the world. The mechanism of tumorigenesis in breast cancer remains to be clarified. miR-421 plays an oncogenic role in many cancers. Although, the clinical significance of miR-421 in patients with breast cancer is still to be investigated. Caspase-10 is one of the initiator of apoptosis. But the relationship between miR-421 and caspase-10 has not been investigated. In the present study, we found that miR-421 was expressed much higher in breast cancer tissues compared to those in adjacent non-tumor tissues. Furthermore, miR-421 promotes cell proliferation and colony formation in vitro. miR-421 inhibits cell apoptosis probably through restraining caspase-10 expression. Thus, miR-421 might be a potential diagnostic maker and therapeutic target for breast cancer.

Entities:  

Keywords:  apoptosis breast cancer.; caspase-10; miRNA-421

Mesh:

Substances:

Year:  2018        PMID: 29322788     DOI: 10.4149/neo_2018_170306N159

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  11 in total

1.  MiR-421 Is Overexpressed and Promotes Cell Proliferation in Non-Small Cell Lung Cancer.

Authors:  Xing Li; Shao-Hua Chen; Jin-Wu Zeng
Journal:  Med Princ Pract       Date:  2019-09-02       Impact factor: 1.927

2.  Downregulation of MiR-196b-5p impedes cell proliferation and metastasis in breast cancer through regulating COL1A1.

Authors:  Xiaoliang Zhu; Xuefeng Rao; Wu Yao; Xia Zou
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

3.  MicroRNA-421 Inhibits Apoptosis by Downregulating Caspase-3 in Human Colorectal Cancer.

Authors:  Yifan Zhou; Xiaowen Cheng; Yufeng Wan; Tingting Chen; Qing Zhou; Zhengguang Wang; Huaqing Zhu
Journal:  Cancer Manag Res       Date:  2020-08-21       Impact factor: 3.989

4.  CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1.

Authors:  Weikai Xiao; Shaoquan Zheng; Yutian Zou; Anli Yang; Xinhua Xie; Hailin Tang; Xiaoming Xie
Journal:  Aging (Albany NY)       Date:  2019-12-19       Impact factor: 5.682

5.  Upregulated expression of miR-421 is associated with poor prognosis in non-small-cell lung cancer.

Authors:  Yunxia Li; Xiaomei Cui; Yongdeng Li; Tingting Zhang; Shuyun Li
Journal:  Cancer Manag Res       Date:  2018-08-13       Impact factor: 3.989

6.  Five miRNAs-mediated PIEZO2 downregulation, accompanied with activation of Hedgehog signaling pathway, predicts poor prognosis of breast cancer.

Authors:  Weiyang Lou; Jingxing Liu; Bisha Ding; Luqi Jin; Liang Xu; Xia Li; Jing Chen; Weimin Fan
Journal:  Aging (Albany NY)       Date:  2019-05-06       Impact factor: 5.682

7.  MicroRNA-421 confers paclitaxel resistance by binding to the KEAP1 3'UTR and predicts poor survival in non-small cell lung cancer.

Authors:  Fu-Gang Duan; Mei-Fang Wang; Ya-Bing Cao; Run-Ze Li; Xing-Xing Fan; Imran Khan; Huan-Ling Lai; Yi-Zhong Zhang; Wendy Wen-Luan Hsiao; Xiao-Jun Yao; Qi-Biao Wu; Liang Liu; Yi-Jun Tang; Elaine Lai-Han Leung
Journal:  Cell Death Dis       Date:  2019-10-28       Impact factor: 8.469

8.  Characteristics of CXCL2 expression in coronary atherosclerosis and negative regulation by microRNA-421.

Authors:  Jun Yang; Hu Liu; Qian Cao; Wei Zhong
Journal:  J Int Med Res       Date:  2020-02       Impact factor: 1.671

9.  lncRNA CCAT1 Acts as a MicroRNA-218 Sponge to Increase Gefitinib Resistance in NSCLC by Targeting HOXA1.

Authors:  Xiang Jin; Xiuhua Liu; Zhen Zhang; Yinghui Guan
Journal:  Mol Ther Nucleic Acids       Date:  2020-01-17       Impact factor: 8.886

10.  Circular RNA_CNST Promotes the Tumorigenesis of Osteosarcoma Cells by Sponging miR-421.

Authors:  Ji-Hai Wang; Xue-Jian Wu; Yong-Zhuang Duan; Feng Li
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.